---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-115141"
form_type: "8-K"
ticker: "MMED"
cik: "0002062583"
company_name: "MiniMed Group, Inc."
filed_at: "2026-10-13T10:00:51+00:00"
generated_at: "2026-10-13T10:05:59.292859+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# MiniMed holders re-elect four Class I directors, ratify PwC, back annual say-on-pay votes

## Summary
- All four director nominees elected at Oct 9, 2026 annual meeting: Kevin E. Lofton (273,936,720 for), David J. Endicott (275,525,168), D. Keith Grossman (273,943,472) and Tim A. Wicks (273,946,011).
- Stockholders ratified PricewaterhouseCoopers LLP as independent auditor for fiscal year ending April 30, 2027, with 278,463,576 votes for, 20,597 against and 1,812 abstained.
- Advisory say-on-pay resolution approved with 276,102,824 for, 91,742 against and 27,666 abstained; 2,263,753 broker non-votes recorded on the proposal.
- Say-on-pay frequency: 276,205,804 votes for annual votes versus 7,990 for three years; MiniMed will hold the advisory vote every one year.

## SEC filing metadata
- accession: 0001104659-26-115141
- form_type: 8-K
- ticker: MMED
- cik: 0002062583
- company_name: MiniMed Group, Inc.
- filed_at: 2026-10-13T10:00:51+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2062583/000110465926115141/0001104659-26-115141-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2062583/000110465926115141/tm2627388d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-115141
- JSON: https://secwatch.observer/filing/0001104659-26-115141.json
- Plain text: https://secwatch.observer/filing/0001104659-26-115141.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.